We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+8.74%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$136B
AUM Growth
+$19.8B
Cap. Flow
+$10.6B
Cap. Flow %
7.76%
Top 10 Hldgs %
11.1%
Holding
5,079
New
591
Increased
1,620
Reduced
1,625
Closed
731

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$964M
2
AAPL icon
Apple
AAPL
+$606M
3
WDAY icon
Workday
WDAY
+$520M
4
PLTR icon
Palantir
PLTR
+$514M
5
SPOT icon
Spotify
SPOT
+$431M

Sector Composition

Rank Sector Weight
1 Technology 13.54%
2 Consumer Discretionary 8.87%
3 Healthcare 8.21%
4 Financials 5.68%
5 Industrials 4.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLS
3326
DELISTED
Apellis Pharmaceuticals
APLS
$638K ﹤0.01%
+20,000
New +$601K
CIEN icon
3327
CALL
Ciena
CIEN
$48.3B
$636K ﹤0.01%
+7,500
New +$538K
SM icon
3328
CALL
SM Energy
SM
$7.04B
$636K ﹤0.01%
16,400
+6,000
+58% +$253K
BBUC
3329
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.6B
$635K ﹤0.01%
26,175
+3,117
+14% +$79.5K
HLN icon
3330
Haleon
HLN
$45.1B
$634K ﹤0.01%
66,458
-339,059
-84% -$3.32M
NLY icon
3331
PUT
Annaly Capital Management
NLY
$17.2B
$633K ﹤0.01%
34,600
+18,900
+120% +$369K
CMRE icon
3332
Costamare
CMRE
$1.86B
$633K ﹤0.01%
+49,247
New +$678K
PERI icon
3333
PUT
Perion Network
PERI
$378M
$633K ﹤0.01%
74,700
ARIS
3334
Aris Mining
ARIS
$3.01B
$632K ﹤0.01%
180,300
-35,600
-16% -$148K
DOO
3335
PUT
Bombardier Recreational Products
DOO
$4.63B
$631K ﹤0.01%
+12,400
New +$644K
FTI icon
3336
PUT
TechnipFMC
FTI
$28.9B
$631K ﹤0.01%
+21,800
New +$621K
RIO icon
3337
CALL
Rio Tinto
RIO
$150B
$629K ﹤0.01%
10,700
+100
+0.9% +$6.39K
CAG icon
3338
Conagra Brands
CAG
$7.38B
$628K ﹤0.01%
+22,638
New +$643K
ELF icon
3339
e.l.f. Beauty
ELF
$4.92B
$628K ﹤0.01%
5,000
-73,408
-94% -$8.8M
BXP icon
3340
PUT
Boston Properties
BXP
$11B
$625K ﹤0.01%
+8,400
New +$681K
JACK icon
3341
PUT
Jack in the Box
JACK
$309M
$625K ﹤0.01%
15,000
-88,500
-86% -$4.08M
KRG icon
3342
Kite Realty
KRG
$5.94B
$623K ﹤0.01%
24,672
-69,219
-74% -$1.82M
RFV icon
3343
Invesco S&P MidCap 400 Pure Value ETF
RFV
$335M
$623K ﹤0.01%
5,133
KALV
3344
DELISTED
KalVista Pharmaceuticals
KALV
$621K ﹤0.01%
73,286
-16,643
-19% -$172K
BWB icon
3345
Bridgewater Bancshares
BWB
$591M
$619K ﹤0.01%
45,795
+13,963
+44% +$205K
OFLX icon
3346
Omega Flex
OFLX
$307M
$619K ﹤0.01%
14,740
-300
-2% -$14.6K
LYEL icon
3347
Lyell Immunopharma
LYEL
$315M
$618K ﹤0.01%
48,313
+24,682
+104% +$489K
HEI icon
3348
CALL
HEICO Corp
HEI
$50.5B
$618K ﹤0.01%
2,600
+1,500
+136% +$389K
VDC icon
3349
Vanguard Consumer Staples ETF
VDC
$8.17B
$616K ﹤0.01%
+2,913
New +$631K
RICK icon
3350
CALL
RCI Hospitality Holdings
RICK
$205M
$615K ﹤0.01%
10,700
-1,000
-9% -$48.8K

Similar funds

D.E. Shaw & Co's Q4 2024 Portfolio in Review

As of Q4 2024, D.E. Shaw & Co held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

D.E. Shaw & Co deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.

  • D.E. Shaw & Co's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
  • D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
  • D.E. Shaw & Co's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
  • D.E. Shaw & Co fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
  • D.E. Shaw & Co's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
  • D.E. Shaw & Co opened 591 new positions and closed 731 in Q4 2024.
  • D.E. Shaw & Co's portfolio value rose 17% quarter-over-quarter to $136B.

Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.